Related Experiment Video
Updated: Dec 2, 2025

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique
Published on: September 28, 2022
Prenatal exposure to perfluoroalkyl substances and cord plasma lipid concentrations
Youping Tian1, Maohua Miao2, Honglei Ji2
1National Management Office of Neonatal Screening Project for CHD, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China; NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, 779 Old Hu Min Road, Shanghai, 200237, China.
Insights
Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) may lower newborn lipid levels. This study found associations between specific PFAS and reduced total cholesterol and HDL-C in cord blood, suggesting disruption of infant lipid metabolism.
Area of Science:
- Environmental Health
- Toxicology
- Pediatrics
Background:
- Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with largely unknown effects on fetal development.
- Prenatal exposure to environmental chemicals is a growing concern for infant health outcomes.
- Lipid metabolism is crucial for neonatal development and long-term health.
Purpose of the Study:
- To investigate the association between prenatal exposure to individual and multiple PFAS and cord blood lipid concentrations in newborns.
- To assess the impact of specific PFAS compounds on total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in neonates.
- To evaluate the combined effects of a mixture of PFAS on neonatal lipid profiles.
Main Methods:
- Prospective cohort study utilizing data from the Shanghai-Minhang Birth Cohort Study.
- Analysis of maternal plasma for eleven PFAS at 12-16 weeks gestation and cord blood for four lipid parameters.
- Application of multiple linear regression and Bayesian Kernel Machine Regression (BKMR) models to assess exposure-outcome associations.
Main Results:
- Increased maternal concentrations of perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), and perfluorotridecanoic acid (PFTrDA) were associated with decreased ln-transformed TC and HDL-C concentrations in cord blood.
- Inverse associations were also observed between PFDA, PFUdA, or PFTrDA and cord TG and LDL-C levels.
- A mixture of eight PFAS showed a suggestively inverse association with all ln-transformed lipid concentrations, with higher exposure linked to lower TC.
Conclusions:
- Prenatal exposure to certain PFAS may negatively impact lipid metabolism in newborns.
- Specific PFAS compounds are associated with reduced levels of key lipids in cord blood.
- These findings highlight the potential endocrine-disrupting effects of PFAS on fetal lipid homeostasis and warrant further investigation.
Abstract:
The effect of prenatal exposure to perfluoroalkyl substances (PFAS) on lipid concentrations in newborns is unknown. Using data from the Shanghai-Minhang Birth Cohort Study, we prospectively assessed the health effects of prenatal exposure to individual and multiple PFAS on cord lipid concentrations. Maternal plasma samples collected at 12-16 weeks of gestation were analyzed for eleven PFAS, and cord blood samples were analyzed for lipids: total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). We used multiple linear regression models to evaluate the associations of each individual PFAS with each lipid parameter, and used Bayesian Kernel Machine Regression (BKMR) models to assess the overall and single-exposure effects of eight PFAS with the detection rate above 80% on cord lipid concentrations. In multiple linear regression models, for each unit increase in ln-transformed maternal concentrations of perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), and perfluorotridecanoic acid (PFTrDA), ln-transformed TC concentration decreased by 0.15 mg/dL (95% confidence interval (CI): -0.25, -0.05), 0.12 mg/dL (95% CI: -0.19, -0.05), 0.12 mg/dL (95% CI: -0.19, -0.05), and 0.05 mg/dL (95% CI: -0.09, -0.01), respectively, and ln-transformed HDL-C concentration decreased by 0.17 mg/dL (95% CI: -0.29, -0.05), 0.12 mg/dL (95% CI: -0.20, -0.03), 0.12 mg/dL (95% CI: -0.20, -0.03), and 0.06 mg/dL (95% CI: -0.11, -0.00), respectively. Statistically significant inverse associations were also observed between ln-transformed concentrations of PFDA, PFUdA, or PFTrDA and ln-transformed cord concentrations of TG and LDL-C. In BKMR models, the mixture of eight PFAS showed suggestively inverse association with all ln-transformed lipid concentrations, such that ln-transformed TC concentration of exposure to the 75th percentile of the mixture was 0.11 units (95% credible interval, -0.21, -0.01) lower than the 25th percentile exposure. Our findings indicated that prenatal exposure to PFAS may disrupt lipid metabolism in newborns.
More Related Videos
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
07:08Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Teratogenicity